Release Date: 25/03/13 16:25 Summary: Non-Renouceable Rights Issue Offer Documents Dispatched Price Sensitive: No Download Document 209.58KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%